Cerebrovascular events primary prevention in metabolic syndrome patients

Aim. To study effects of therapy with bisoprolol (Concor®) and deproteinized hemoderivate (Actovegin®) on circadian blood pressure profile (CBPP), carbohydrate, lipid metabolism, and cerebral perfusion in patients with metabolic syndrome (MS) and mild arterial hypertension (AH). Material and methods...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: V. B. Mychka, K. M. Mamyrbaeva, V. B. Sergienko, V. P. Masenko, I. E. Chazova
Formato: Artigo
Idioma:Russo
Publicado em: «SILICEA-POLIGRAF» LLC 2006-04-01
Colecção:Кардиоваскулярная терапия и профилактика
Assuntos:
metabolic syndrome
arterial hypertension
Acesso em linha:https://cardiovascular.elpub.ru/jour/article/view/1127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados